Literature DB >> 9156379

Antibiotic-resistant pneumococci in pediatric disease.

K P Klugman1, I R Friedland.   

Abstract

The surveillance of pneumococcal resistance in nasopharyngeal isolates is a practical way to determine the prevalence of resistant strains and is a reasonable predictor of resistance in systemic isolates. The increasing prevalence of resistance is shifting the distribution of invasive pneumococcal serotypes toward those included in conjugate vaccines. If these vaccines reduce carriage, they may eliminate or greatly reduce the prevalence of resistant strains. Meningitis is the most important infection caused by PRP for which penicillin or ampicillin therapy is inappropriate. Although the extended spectrum cephalosporins will be effective for most cases of PRP meningitis, it is clear that such therapy is not foolproof. It is important for the laboratory to test CSF isolates not only for penicillin resistance but also for resistance to the cephalosporins. beta-Lactam antibiotics can still be considered appropriate empiric therapy for otitis media, pneumonia, or sepsis. However, occasional treatment failures with these agents may necessitate use of alternative therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9156379     DOI: 10.1089/mdr.1995.1.5

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  Emergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin.

Authors:  C Doit; C Loukil; F Fitoussi; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; N Peyrard; A Pechinot; M Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland.

Authors:  J Wüst; E Huf; F H Kayser
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 4.  Antimicrobial agents for community-acquired respiratory tract infections.

Authors:  A L Barry
Journal:  Infection       Date:  1995       Impact factor: 3.553

5.  Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada.

Authors:  D Greenberg; D P Speert; E Mahenthiralingam; D A Henry; M E Campbell; D W Scheifele
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

6.  Contribution of vaccines to our understanding of pneumococcal disease.

Authors:  Keith P Klugman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

7.  Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children.

Authors:  Catherine Doit; Chawki Loukil; Pierre Geslin; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 8.  Prevention of otitis media by vaccination.

Authors:  Fiona Russell; Kim Mulholland
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.